Arbutus Biopharma (ABUS) Interest Expenses (2017 - 2025)
Historic Interest Expenses for Arbutus Biopharma (ABUS) over the last 9 years, with Q3 2025 value amounting to $23000.0.
- Arbutus Biopharma's Interest Expenses fell 2068.97% to $23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $109000.0, marking a year-over-year decrease of 2781.46%. This contributed to the annual value of $137000.0 for FY2024, which is 7015.25% down from last year.
- Per Arbutus Biopharma's latest filing, its Interest Expenses stood at $23000.0 for Q3 2025, which was down 2068.97% from $28000.0 recorded in Q2 2025.
- Arbutus Biopharma's 5-year Interest Expenses high stood at $772000.0 for Q1 2021, and its period low was $23000.0 during Q3 2025.
- For the 5-year period, Arbutus Biopharma's Interest Expenses averaged around $276736.8, with its median value being $171000.0 (2023).
- Per our database at Business Quant, Arbutus Biopharma's Interest Expenses plummeted by 8927.74% in 2023 and then crashed by 1764.71% in 2025.
- Quarter analysis of 5 years shows Arbutus Biopharma's Interest Expenses stood at $560000.0 in 2021, then tumbled by 44.82% to $309000.0 in 2022, then tumbled by 85.76% to $44000.0 in 2023, then plummeted by 31.82% to $30000.0 in 2024, then fell by 23.33% to $23000.0 in 2025.
- Its Interest Expenses was $23000.0 in Q3 2025, compared to $28000.0 in Q2 2025 and $28000.0 in Q1 2025.